EUVIMEDEUVIMED entdecken
Crossref

Prognostic Significance of Tumour Infiltrating Lymphocytes in Canine Oral Malignant Melanoma Treated With Anti‐Programmed Cell Death Ligand 1 ( PD ‐ L1 ) Antibody Therapy

Shintaro Kamo iD, Naoya Maekawa, Ayano Kudo iD, Akinori Yamauchi, Sho Yoshimoto iD, Yuma Harada, Satoru Konnai iD, Tomohiro Okagawa iD, Hayato Nakamura, Yumiko Kagawa iD, Junichi Kamiie, Keiichi Yamamoto und 1 weitere

Veterinary and Comparative Oncology · 2026

DOI: 10.1111/vco.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2026. Verfasst von Shintaro Kamo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Small Animal Surgery, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Dog Diseases, Mouth Neoplasms, Melanoma. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) have emerged as a promising therapeutic strategy for canine oral malignant melanoma (OMM). However, only a subset of cases have shown clinical responses. Additionally, predictive biomarkers for the efficacy of ICIs in veterinary medicine are yet to be established. Tumour‐infiltrating lymphocytes (TILs) are predictive biomarkers for ICI therapy in humans. In this study, we aimed to investigate the predictive utility of TILs for canine OMM treated with ICI therapy. Immunohistochemistry was performed on pre‐treatment pathological tissues to detect cells positive for CD3 (pan‐T cell marker), Granzyme B (cytotoxic T lymphocyte or natural killer cell marker) and Foxp3 (regulatory T cell marker). Further, we analysed the infiltration patterns of these cells and their prognostic utility for anti‐programmed cell death ligand 1 (PD‐L1) antibody therapy. There were variances in the infiltration levels of each TIL subset; further, we observed several TIL infiltration patterns in canine OMM. Survival analysis revealed that high infiltration of CD3 + and Granzyme B + cells was significantly associated with prolonged progression‐free survival and overall survival. Furthermore, the immune cell composition ratio, which reflected the balance between cytotoxic and regulatory cells, was significantly associated with survival time. These findings suggest that canine OMM exhibits immunological phenotypes analogous to those observed in human cancers. Taken together, the TIL profile holds significant potential as a prognostic biomarker for canine OMM treated with anti‐PD‐L1 antibody therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingDog DiseasesMouth NeoplasmsMelanomaImmune Checkpoint InhibitorsB7-H1 AntigenAnimalsDogsPrognosisFemaleMale

Stichwörter der Autor:innen

immune checkpoint inhibitororal malignant melanomapredictive biomarkertumour infiltrating lymphocytes

Substanzen

Immune Checkpoint InhibitorsB7-H1 Antigen

Autor:innen und Institutionen

  • Laboratory of Small Animal Surgery, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan.
  • Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Cancer Research Unit, One Health Research Center, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Hokkaido, Japan.
  • Veterinary Research Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan.

ORCID-Profile: Shintaro Kamo, Ayano Kudo, Sho Yoshimoto, Satoru Konnai, Tomohiro Okagawa, Yumiko Kagawa, Satoshi Takagi

Zitieren

APA

Kamo, S., Maekawa, N., Kudo, A., Yamauchi, A., Yoshimoto, S., Harada, Y., Konnai, S., Okagawa, T., Nakamura, H., Kagawa, Y., Kamiie, J., Yamamoto, K., & Takagi, S. (2026). Prognostic Significance of Tumour Infiltrating Lymphocytes in Canine Oral Malignant Melanoma Treated With Anti‐Programmed Cell Death Ligand 1 ( PD ‐ L1 ) Antibody Therapy. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.70052

Vancouver

Kamo S, Maekawa N, Kudo A, Yamauchi A, Yoshimoto S, Harada Y, et al. Prognostic Significance of Tumour Infiltrating Lymphocytes in Canine Oral Malignant Melanoma Treated With Anti‐Programmed Cell Death Ligand 1 ( PD ‐ L1 ) Antibody Therapy. Veterinary and Comparative Oncology. 2026. doi:10.1111/vco.70052

BibTeX
@article{Kamo2026,
  author = {Kamo, Shintaro and Maekawa, Naoya and Kudo, Ayano and Yamauchi, Akinori and Yoshimoto, Sho and Harada, Yuma and Konnai, Satoru and Okagawa, Tomohiro and Nakamura, Hayato and Kagawa, Yumiko and Kamiie, Junichi and Yamamoto, Keiichi and Takagi, Satoshi},
  title = {Prognostic Significance of Tumour Infiltrating Lymphocytes in Canine Oral Malignant Melanoma Treated With Anti‐Programmed Cell Death Ligand 1 ( PD ‐ L1 ) Antibody Therapy},
  journal = {Veterinary and Comparative Oncology},
  year = {2026},
  doi = {10.1111/vco.70052}
}
Kostenlos starten →